Managing dying with chronic heart failure
|
|
- Aubrey Lloyd
- 6 years ago
- Views:
Transcription
1 Heart failure Managing dying with chronic heart failure Chronic heart failure (CHF) is predominantly a pathology of old age affecting 5% of those over 75 years of age. It is more common than cancer and the long-term survival is considerably worse than most cancers as annual mortality is 50% in severe cases. Around 60,000 of heart failure patients die annually but only 6% of those dying with CHF are referred to palliative care. 1 Dr Shobana Athimulam. Clinical Research Fellow Department of Gastroenterology and Neuroendocrine Tumour Unit, Royal Free Hospital, London Dr Shahid A Khan Consultant Physician, Lister Hospital, Corey s Mill Lane, Stevenage, Herts ShahidAK@aol.com Chronic heart failure (CHF) is a disease with slow physical decline with its hallmark being unpredictable disease exacerbations. Sudden cardiac death is common but many patients show a protracted downward spiral. Therefore principles of managing end of life issues in cancer patients do not apply to CHF. In CHF, most patients require a coordinated approach to care in their own homes and are often the most effective assessors of their needs. 1 The goal of managing these patients is to aim for a dignified death. 2 A timeline approach 1 3 The last few years For many patients with CHF, life can be an ongoing crisis. Slow transition makes it a life event rather than a crisis and no specific trajectory can be reliably anticipated. Patients accept disability and they gradually adjust to a slower pace of life to fit within the limitations imposed by CHF. For many, the carers and their physicians share passive acceptance of disability. This is one of the main issues, which contribute to the difficulties in identifying need for palliative care. The last few months The psychological aspect of a dying patient needs to be addressed during this period. The fear of dying does not increase with age and many elderly patients with CHF are well aware of the possibility of dying. With deterioration of symptoms some go through phases of depression or anger but some may exhibit denial. Most patients accept the outcome but are concerned about discomfort and dependency in later stages. Concern regarding the well-being of spouses is not uncommon. The last hours or days of life Appropriate prescribing is essential and gradual discontinuation of drugs commonly used in CHF should be considered. Withdrawal could be achieved without deterioration of symptoms with some medications such as hydralazine, nitrates, beta-blockers, spironolactone, particularly when faced with low blood pressure, which is common in these patients. Discuss the discontinuation of non essential drugs particularly the ones prescribed for prolongation of life (eg. statins) and prophylaxis (eg. aspirin and clopidogrel). The managing team should review the suitability of anticoagulants at this stage. Other medications such as ACE inhibitors may need to be discontinued in the last few days or last few hours of life. Where possible, loop diuretics are continued for symptomatic management for as long as possible. 26 September 2012 Midlife and Beyond GM2
2 Box 1: Systemic failure in heart failure Locomotor failure falls and instability Bone marrow failure Hb <10g/l Renal failure worsening creatinine, elevated potassium Brain failure delirium Respiratory failure hypoxia Gastrointestinal failure ascites, nausea, vomiting, constipation Hepatobiliary failure worsening liver function Dermatolgy failure pressure sores/leg ulcers Diagnosis of dying So when do we say the patient is dying with heart failure? In order to make this diagnosis, one should be able to recognise the accelerated phase of dying. This is a clinical skill and in CHF, unfortunately, is particularly difficult to recognise. The answer lies in recognition of the accelerated phase of dying when a patient develops multitude of systemic failures as shown in Box 1. However, there are several barriers to diagnosing accelerated phase of dying. Lack of a clear diagnosis leads to pursuance of unrealistic or futile interventions. Failure to recognise key symptoms and signs is not uncommon. One important factor is the managing team s concern about withdrawing or withholding active treatment based on fear of foreshortening life. Lack of knowledge about prescribing, poor communication skills, cultural and spiritual barriers and medico legal concerns Box 3: Symptoms in last hours or days Dyspnoea Pain Confusion Anxiety Depression Nausea & vomiting Constipation Urinary incontinence Box 2: Markers of poor prognosis Severe disease Frailty Poor nutritional status Multiple comorbidities Depression Impaired quality of life Extreme old age Social isolation all contribute to futile interventions and delay in instituting palliative care. 2 To overcome barriers in diagnosing dying patients, working as a member of a multi-professional team is essential. Sensitive communication and appropriate referrals to other members of the specialist team are paramount. Early recognition of the key symptoms and signs mentioned above is vital and avoiding nonessential investigations and treatment is crucial. 2 More often than not, the attending team concentrates on the distressing presentation of an acute exacerbation and overlooks the stepwise deterioration occurring in the long run. The involvement of palliative care in CHF when and why? Palliative care in CHF is based on managing distressing symptoms commonly encountered at the end of life. These symptoms are distressing but are often overlooked by health professionals as being relatively less significant. Coordination of multiple disciplines to address patients and carers concerns is at the heart of palliative care decision-making. 1 The World Health Organisation has recommended that palliative care be considered earlier along with other modalities, which prolong life in this disabling chronic disease. In CHF it is important not to look for a single transition point to switch to palliative care approach. Holistic assessments of needs could be linked with milestones throughout the patient s illness. Worsening symptoms, deteriorating renal functions, low blood pressure, falls, development of anaemia and hyponatraemia are milestones which should alert the management team to consider end of life care. 4 The trajectory slowly goes down and each time the patient comes out of hospital there is deterioration in function and symptoms, thus, GM2 Midlife and Beyond 2012 September 27
3 Heart failure Box 4: Management of end of life symptoms Pain Diamorphine 10mg sc via syringe driver over 24 hours and oramorph 2.5 5mg prn and titrate dose accordingly. Consult Palliative Care team. Nausea and vomiting Metoclopramide 10mg tds oral or sc to improve symptoms, or Haloperidol 1.5 3mg (oral or sc) over 24 hours, or Avoid cyclizine. Constipation Stool softener Docusate sodium mg orally as required Stimulant laxative senna 2 tablets daily or co-danthramer 1 2 capsules or 5 10mls orally as required Restlessness Midazolam - 2.5mg sc PRN or consider 10mg sc over 24 hours via syringe driver or Haloperidol 1.5 3mg orally over 24 hours or 2.5mg sc over 24 hours via syringe driver or Lorazepam 0.5 1mg over 24 hours or diazepam 2mg daily Dry mouth Sipping semi frozen drink, sucking ice chips or chewing gum Moisturising cream or soft paraffin to the lips, chewing pineapple or saliva substitute sprays Breathlessness Symptomatic oxygen administration Discontinue beta blockers Use of fan helps Cough Simple linctus or codeine linctus 5 10 mls orally PRN Low dose oral morphine solution may help. For retained secretions glycopyrronium 0.8mg 2.4mg over 24 hours via syringe driver Others: Implantable ICD should be switched off though pacing function should continue. making frequent hospital admission a significant milestone for poor prognosis. 1 Other markers for poor prognosis are detailed in Box 2 and should alert the team to consider palliative approach. Despite poor prognosis there is a tendency for doctors to overestimate survival in these patients. The last few days of life what can we do? Appropriate prescribing is required for symptoms in the last few days of life (Box 3). Over 75% of patients dying with CHF experience 28 September 2012 Midlife and Beyond GM2
4 pain. Oramorph 2.5-5mg orally every four hours or diamorphine 10mg s/c via syringe driver over 24 hours may be needed to control pain. This not only relieves pain, but may also relieve anxiety, distress and reduces myocardial oxygen demand. Transient venodilatation leads to reduction in preload, cardiac filling pressures, and pulmonary congestion and has added benefit of inhibiting cough. Non steroidal anti-inflammatory drugs should be avoided in patients with CHF. Nausea and vomiting are common symptoms in the last few days. They may be related to eating, gastric stasis, early satiety, hepatomegaly or ascites. Metoclopramide 10mg orally or subcutaneously may help to improve symptoms. Nausea predominantly caused by renal impairment or drugs, improves with haloperidol 1.5mg orally or subcutaneously. Cyclizine should be avoided as it may worsen heart failure. Constipation is a common symptom and a stool softener (eg. docusate sodium mg) may be required. A stimulant laxative (eg. senna 2 tablets or co-danthramer 1-2 capsules or 5 10mls) may be needed but avoid if the patient is incontinent of urine and or faeces. Restlessness is common in the terminal phase and usually requires mitazolam 2.5mg s/c or 10mg s/c via syringe driver over 24 hours. Haloperidol 1.5 3mg orally or 2.5mg s/c or via infusion over 24 hours may be needed. Anxiety is not uncommon and usually requires lorazepam 0.5 1mg or diazepam 2mg once a day. Dry mouth is very common in the last few days or hours of life. Sipping semi-frozen drinks, sucking ice chips or chewing gum may help. Moisturising cream or soft paraffin to the lips, chewing pineapple or saliva substitute sprays may be of help. Breathlessness is major problem in patients with CHF. There is no clear evidence that oxygen at rest or when ambulatory is beneficial in CHF. However it has a role in symptomatic relief in palliative care. Discontinuation of beta-blockers may be needed to help shortness of breath. Use of a fan often improves the symptoms of breathlessness. Cough is a difficult symptom to manage but is often attributed to ACE inhibitors. Cough suppressants for dry irritable cough eg. simple linctus 5 10mls may help. Codeine linctus 5 10mls or low dose oral morphine solution may be needed. Some patients respond to nebulised normal saline. Glycopyrronium bromide micrograms may be required for some patients to relieve symptoms of
5
6 respiratory distress. In terminally ill patients with CHF, Implantable Cardioverter Defibrillator (ICD) should be switched off though pacing function could continue. The resuscitation status of these patients should be reviewed and decided upon. Conclusion Medicine has progressed a great deal over the years but it has also contributed to prolonging the dying process. Diagnosing dying early and effective communication are key skills that needs to be learnt. A single point of transition to palliative care is impractical in CHF as the disease course is prolonged and unpredictable. Most patients do not need specialist palliative care but if required, a timely referral should be done and appropriate measures should be taken to ensure that the patient is comfortable at the terminal stage. There is a growing need to educate health workers and society that accepting death as a natural phenomenon, and not a failure in treatment, is the key to achieving a good death for these patients. Conflict of interest: none declared Reference 1. National End of Life Care Programme/ NHS improvement. End of life care in heart failure. A framework for implementation. (2010). 2. Ellershaw J, Ward C. Care of the dying patient: the last hours or days of life. BMJ. 2003; 326(7379): Cowburn PJ, Cleland JGF, Coats, AJS, Comajda M. Risk stratification in chronic heart failure. Eur Heart J 1998; 19: SWL Supportive and Palliative Care Group and SWL Cardiac Network. Symptom control guidelines and key information in end stage heart failure. (2008/2009) GM2 Midlife and Beyond 2012 September 33
Care in the Last Days of Life
Care in the Last Days of Life Introduction This guideline is an aid to clinical decision making and good practice in person-centred care for patients who are deteriorating and at risk of dying. The patient
More informationSymptom Management Guidelines for End of Life Care
Symptom Management Guidelines for End of Life Care The following pages are guidelines for the management of common symptoms in the last few days of life. General principles: 1. Consider how symptoms can
More informationSupporting Last Days of Life Symptom Control Medication Guidance: Algorithm. Agitation & Anxiety
Agitation & Anxiety (Exclude or treat REVERSIBLE causes*) Patient is anxious / frightened, but lucid Patient is confused, agitated and / or hallucinating MIDAZOLAM 2.5-5mg s/c (Max total 24 hour dose of
More informationManaging Respiratory Symptoms - Breathlessness, Cough and Secretions. Dr Laura Healy. Palliative Medicine Registrar, Beaumont Hospital.
Managing Respiratory Symptoms - Breathlessness, Cough and Secretions. Dr Laura Healy. Palliative Medicine Registrar, Beaumont Hospital. Things to consider: 1. Very common symptoms. 2. Can occur in any
More informationRenal Palliative Care Last Days of Life
Renal Palliative Care Last Days of Life Introduction This guideline is an aid to clinical decision-making and good practice for patients with stage 4-5 chronic kidney disease (egfr
More informationSYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL
SYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL If a patient is believed to be approaching the end of their life, medication should be prescribed in anticipation
More informationPalliative care for heart failure patients. Susan Addie
Palliative care for heart failure patients Susan Addie Treatments The most common limiting and distressing complaint is of fatigue and breathlessness. Optimal treatment strategies relieve symptoms, improves
More informationAlgorithms for Symptom Management. In End of Life Care
Algorithms for Symptom Management In End of Life Care The Use of Drugs Beyond Licence (off label) -The Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK regulates the activity of the
More informationPAIN MANAGEMENT Patient established on oral morphine or opioid naive.
PAIN MANAGEMENT Patient established on oral morphine or opioid naive. Important; It is the responsibility of the prescriber to ensure that guidelines are followed when prescribing opioids. Every member
More informationPAIN MANAGEMENT Person established taking oral morphine or opioid naive.
PAIN MANAGEMENT Person established taking oral morphine or opioid naive. Important; it is the responsibility of the prescriber to ensure that guidelines are followed when prescribing opioids. Every member
More informationSpecialist palliative care for patients with heart failure. Dr Katie Taylor Consultant in Palliative Medicine
Specialist palliative care for patients with heart failure Dr Katie Taylor Consultant in Palliative Medicine Objectives Identify which patients to refer to hospice Review symptom management Think about
More informationMMG035 Symptom Management Guidelines for a Person thought to be in the Last Few Days and Hours of Life
MMG035 Symptom Management Guidelines for a Person thought to be in the Last Few Days and Hours of Life The following pages are guidelines for the management of common symptoms for a person thought to be
More informationSymptom Control in Heart Failure. Dr Claire L Hookey
Symptom Control in Heart Failure Dr Claire L Hookey Heart Failure symptoms Class III/IV CHF, mean 67.1 years, mean EF 22.3% Most prevalent symptoms:- lack of energy (66%) dry mouth (62%) shortness of breath
More informationSupportive Care. End of Life Phase
Supportive Care End of Life Phase Guidelines for Health Care Professionals In the care of patients with established renal failure who are in the last days of life References: Chambers E J (2004) End of
More informationGUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS
GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS Bristol Palliative Care Collaborative Contact Numbers: Hospital Specialist Palliative Care Teams: North Bristol 0117 4146392 UH Bristol 0117
More informationConservative Management of Uraemia
Conservative Management of Uraemia Information for Health Professionals Renal Department The York Hospital and Scarborough Hospital Tel: 01904 725370 For more information, please contact: The Renal Specialist
More informationPAIN AND SYMPTOM MANAGEMENT GUIDANCE IN THE LAST DAYS OF LIFE
PAIN AND SYMPTOM MANAGEMENT GUIDANCE IN THE LAST DAYS OF LIFE Reference: DCM029 Version: 1.1 This version issued: 07/06/18 Result of last review: Minor changes Date approved by owner (if applicable): N/A
More informationPalliative care for patients with brain cancer
Palliative care for patients with brain cancer Lyn Cave Clinical Nurse Specialist Palliative Care Hospital2Home (H2H) Dr Jayne Wood Clinical Lead Palliative Care The Royal Marsden and Royal Brompton Palliative
More informationFor patients and their carers this means smoother symptom control, better support in a crisis, and avoidance of admission if that is their choice.
Bedfordshire Palliative Care Palliative Care Medicines Guidance This folder has been produced to support professionals providing palliative care in any setting. Its aim is to make best practice in palliative
More informationMND Just in Case kit Information for GPs
MND Just in Case kit Information for GPs What is the MND Just in Case kit? 2 Motor neurone disease (MND) is a progressive and terminal disease that results in degeneration of the motor neurones in the
More informationCare of the dying in End Stage Kidney Disease (ESKD) - Conservative. Elizabeth Josland Renal Supportive Care CNC St George Hospital
Care of the dying in End Stage Kidney Disease (ESKD) - Conservative Elizabeth Josland Renal Supportive Care CNC St George Hospital Introduction What does conservative management look like? How does the
More informationPRESCRIBING GUIDELINES FOR SYMPTOM MANAGEMENT IN THE DYING PATIENT
PRESCRIBING GUIDELINES FOR SYMPTOM MANAGEMENT IN THE DYING PATIENT A collaboration between: St. Rocco s Hospice, Bridgewater Community Healthcare NHS Trust, NHS Warrington Clinical Commissioning Group,
More informationThe last days of life Linda Magann CNC Palliative Care St George Hospital I m not afraid of dying, I just don t want to be there when it happens Woody Allen Palliative Care is an approach that improves
More informationThe last days of life in hospital and at home
The last days of life in hospital and at home Beaumont Multi-disciplinary Palliative Care Study Day 28/9/2017 Dr Sarah McLean Consultant in Palliative Medicine St Francis Hospice Beaumont Hospital Overview
More informationBREATHLESSNESS MANAGEMENT
Guideline Name: Breathlessness BACKGROUND Breathlessness is a common symptom in patients with cancer, end-stage heart failure and end-stage chronic obstructive pulmonary disease (COPD). There are many
More informationAnalgesia. This is widely used in palliative care. It has antipyretic and analgesic effects but no anti-
Page 1 of 8 Analgesia The World Health Organisation (WHO, 1990) has devised a model to assist health care professionals in the management of cancer pain. The recommendations include managing pain, by the
More informationCare of the Dying. For dosing in severe renal impairment see separate guidance for care of the dying in severe renal failure.
Care of the Dying Early diagnosis of the dying process allows for adequate preparation of the patient, the family and the carers. This clinical guidance covers the prescribing and management of patients
More informationApproach to symptom control near the end-of-life
Approach to symptom control near the end-of-life 18 Sept 2011 Dr Alethea Yee Senior Consultant, Department of Palliative Medicine National Cancer Centre,Singapore What is end of life? No precise definition
More informationPalliative Care Out-of-hours. A resource pack for West Dorset. Contents:
Palliative Care Out-of-hours. A resource pack for West Dorset Contents: Section 1 Supply of drugs DCH Pharmacy hours and arrangements How to contact a community pharmacist out of hours Palliative care
More informationGuidelines: EOLC Symptom Control for Patients with Normal Renal Function (in Wandsworth)
Guidelines: EOLC Symptom Control for Patients with Normal Renal Function (in Wandsworth) Policy Number : DC020 Issue Date: October 2014 Review date: October 2016 Policy Owner: Head Community Services Monitor:
More informationRenal Prescribing at End of Life Guidance for Anticipatory prescribing for patients in renal failure (egfr<30) at the end of life
Guidance for Anticipatory prescribing for patients in renal failure (egfr
More information8. Pharmacological Management
8. Pharmacological Management Neurohormonal deactivation 1. Adrenaline Beta Blockers Dose Side Effects Monitoring Neurohormonal Deactivation 2. Angiotensin II ACE Inhibition Dose Side Effects Monitoring
More informationBreathlessness in advanced disease. February 2017
Breathlessness in advanced disease February 2017 Breathlessness Managing breathlessness in primary care Chronic breathlessness Acute exacerbation of breathlessness Breathlessness at end of life Breathlessness
More informationImplementing the recommendation on medication management and symptom control
Implementing the recommendation on medication management and symptom control Mike Grocott Professor of Anaesthesia and Critical Care Medicine University of Southampton Consultant in Critical Care Medicine
More informationEnd of life prescribing guidance
End of life prescribing guidance Introduction This guidance has been prepared to ASSIST IN DECISION MAKING for the prescribing and monitoring of medicines useful in the management of symptoms commonly
More informationPalliative care competencies: is it for all? Khon Kaen International Conference in Palliative Care 2018
Palliative care competencies: is it for all? Khon Kaen International Conference in Palliative Care 2018 Definition Competence The ability to do something successfully or efficiently For us it means reaching
More informationGUIDELINES FOR PRESCRIBING AT THE END OF LIFE FOR PATIENTS WITH RENAL IMPAIRMENT (estimated glomerular filtration rate<30)
GUIDELINES FOR PRESCRIBING AT THE END OF LIFE FOR PATIENTS WITH RENAL IMPAIRMENT These guidelines have been produced in collaboration with Dr Lucy Smyth, Consultant in Renal Medicine, Royal Devon and Exeter
More informationCommunity and Mental Health Services. Palliative Care. Criteria and
Community and Mental Health Services Specialist Palliative Care Service Referral Criteria and Guidance November 2018 Specialist Palliative Care Service Referrals These guidelines cover referrals for patients
More informationDoncaster & Bassetlaw Cancer Locality. Palliative Care Core Formulary
Doncaster & Bassetlaw Cancer Locality Palliative Core Formulary Approved by Doncaster & Bassetlaw Hospitals NHS Foundation Trust Drugs and Therapeutics Committee. DJ14/2155 Oct 2014 Review date: Oct 2017
More informationRegional Renal Training
Regional Renal Training Palliative and End of Life Care Dr Clare Kendall North Bristol NHS Trust Advanced Kidney Disease Dialysis/Transplant Conservative Management Deteriorating despite dialysis/failing
More informationSymptom Control in the Community Setting. Dr Andrew Tysoe-Calnon
Symptom Control in the Community Setting Dr Andrew Tysoe-Calnon Lead Consultant t Common symptoms Pain Agitation Shortness of breath Nausea and vomiting Intestinal obstruction Confusion Pain Occurs in
More informationCare of the Dying Management in Severe Renal Failure
Care of the Dying Management in Severe Renal Failure Clinical Guideline Early recognition of the dying process allows for adequate preparation of the patient, the family and the carers. This clinical guidance
More informationManaging Symptoms in End of Life Care
Unit Code: PT2/3/EA/004 This unit has 4 learning outcomes. LEARNING OUTCOMES The learner will: 1. Understand the effects of symptoms in relation to end of life care 2. Be able to manage symptoms of end
More informationTreating the symptoms of kidney failure
Treating the symptoms of kidney failure Information for patients, relatives and carers Renal Department The York Hospital and Scarborough Hospital Tel: 01904 725370 For more information, please contact:
More informationSpecialist Palliative Care Service Referral Criteria and Guidance
Specialist Palliative Care Service Referral Criteria and Guidance Specialist Palliative Care Service Referrals These guidelines cover referrals for patients with progressive terminal illness, whether
More informationSpecialist Palliative Care Referral for Patients
Specialist Palliative Care Referral for Patients This guideline covers referrals for patients with progressive terminal illness, whether due to cancer or other disease. For many patients in the late stages
More informationCare of the Dying Management in Severe Renal Failure
Care of the Dying Management in Severe Renal Failure Clinical Guideline Early diagnosis of the dying process allows for adequate preparation of the patient, the family and the carers. This clinical guidance
More informationEAST LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE
EAST LANCASHIRE SPECIALIST PALLIATIVE CARE TEAM EAST LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE Reviewed and updated August 2009 Next review date August 2011 Approved
More informationANTICIPATORY PRESCRIBING FOR PATIENTS AT END OF LIFE WITH RENAL IMPAIRMENT
ANTICIPATORY PRESCRIBING FOR PATIENTS AT END OF LIFE WITH RENAL Doses of opiates must be proptional to current analgesic medication Please refer ALL patients on Methadone Ketamine to SPCT f advice. Patients
More informationSyringe driver in Palliative Care
Syringe driver in Palliative Care Introduction: Syringe drivers are portable, battery operated devices widely used in palliative care to deliver medication as a continuous subcutaneous infusion over 24
More informationTracy Ward Highly Specialist Respiratory Nurse Rotherham NHS Foundation Trust
Interstitial Lung Disease (ILD) Tracy Ward Highly Specialist Respiratory Nurse Rotherham NHS Foundation Trust The views expressed in this presentation are those of the speaker and are not necessarily those
More informationWaterloo Wellington (WW) Symptom Management Guideline for the End of Life (EOL) Medication Order Set for Long Term Care (LTC)
Waterloo Wellington (WW) Symptom Management Guideline for the End of Life (EOL) Medication Order Set for Long Term Care (LTC) May 2018 THE WATERLOO WELLINGTON SYMPTOM MANAGEMENT GUIDELINE FOR THE END OF
More informationThis survey aims to look at individual practice and can be completed by any healthcare professional.
This survey aims to look at individual practice and can be completed by any healthcare professional. If you have any questions about how this form should be completed please contact Dr Grace Ting (ghlting@doctors.net.uk)
More informationEnd of Life Care in Dementia. Sue Atkins Dignity in Care/Dementia/Learning Disabilities Clinical Nurse Specialist
End of Life Care in Dementia Sue Atkins Dignity in Care/Dementia/Learning Disabilities Clinical Nurse Specialist Objectives Understanding the decline in people with dementia To recognise when patients
More informationAPHN. Shortness of breath. Ednin Hamzah CEO, Hospis Malaysia.
APHN Shortness of breath Ednin Hamzah CEO, Hospis Malaysia ednin@hospismalaysia.org What is it? a subjective experience of difficult and uncomfortable breathing American Thoracic Society What do the patients
More informationRegional Breathlessness Audit - Case Note Survey. 1. Introduction. Regional Breathlessness Audit - Case Note Survey. 2.
Regional Breathlessness Audit - Case te Survey 1. Introduction Please complete this form for your case note review. Cases used may be PROSPECTIVE AND/OR RETROSPECTIVE. Please log as many cases as you can.
More informationSpecialist Palliative Care Audit and Guidelines Group (SPAGG)
Specialist Palliative Care Audit and Guidelines Group (SPAGG) Clinical Guideline for the Prescribing and Administration of Furosemide via continuous subcutaneous infusion (CSCI) for Heart Failure Patients
More informationIn our patients the cause of seizures can be broadly divided into structural and systemic causes.
Guidelines for the management of Seizures Amalgamation and update of previous policies 7 (Seizure guidelines, ND, 2015) and 9 (Status epilepticus, KJ, 2011) Seizures can occur in up to 15% of the Palliative
More informationPrimary Diagnosis YES NO ICD - Code Cancer Cognitive impairment Cardiac Respiratory Neurological Musculoskeletal Respiratory Other
Chart review date: / / Reviewer: Centre Name: Hospital Home RACF DOB: / / AGE: GENDER: Male Female Admission Date: / / Death Date: / / 1. DIAGNOSIS Primary Diagnosis YES NO ICD - Code Cancer Cognitive
More informationPENNINE LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE
PENNINE LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE Originally produced: July 2006 First Review: August 2009 Second Review: November 2011 For review November 2013 Approved
More informationEnd of Life Care in IJN Our journey. Dato Dr. David Chew Soon Ping Consultant Cardiologist National Heart Institute Malaysia
End of Life Care in IJN Our journey Dato Dr. David Chew Soon Ping Consultant Cardiologist National Heart Institute Malaysia End of Life Dying is final part of everyone journey in life Deaths used to occur
More informationINTEGRATED CARE PATHWAY (ICP) FOR THE DYING ADULT
INTEGRATED CARE PATHWAY (ICP) FOR THE DYING ADULT PLEASE INFORM THE PALLIATIVE CARE TEAM ON COMMENCEMENT OF THIS ICP (EXT 8958) ICP Start Date Patient s Name. Ward. Consultant.. Named Specialist Nurse
More informationVentilation/End of Life Neuromuscular Disorders. Dr Emma Husbands Consultant Palliative Medicine
Ventilation/End of Life Neuromuscular Disorders Dr Emma Husbands Consultant Palliative Medicine Emma.Husbands@glos.nhs.uk Contents Cases NIV and palliation and ethical bits APM guidelines Important bits
More informationOxford Kidney Unit A guide to conservative kidney management. Information for Healthcare Professionals
Oxford Kidney Unit A guide to conservative kidney management Information for Healthcare Professionals What is conservative kidney management? Some people with advanced kidney disease (chronic kidney disease
More informationThree triggers that suggest that patients could benefit from a hospice palliative care approach
Why is it important to identify people nearing the end of life? About 1% of the population dies each year. Although some deaths are unexpected, many more in fact can be predicted. This is inherently difficult,
More informationFacts About Morphine and Other Opioid Medicines In Palliative Care. Find out more at: palliativecare.my. Prepared by: Printing sponsored by:
Facts About Morphine and Other Opioid Medicines In Palliative Care Find out more at: palliativecare.my Prepared by: Printing sponsored by: What is this brochure about? Opioid medicines are pain relievers.
More informationPalliative Care and Paediatric Cardiac Patients 5 th Annual APPM Paediatric Palliative Care Study Day
Palliative Care and Paediatric Cardiac Patients 5 th Annual APPM Paediatric Palliative Care Study Day Dr Caroline Jones Consultant Fetal and Paediatric Cardiologist Alder Hey Children s Hospital, Liverpool
More informationRenal Supportive Care. Renal Supportive Care Symposium 2013 Elizabeth Josland CNC
Renal Supportive Care. Renal Supportive Care Symposium 2013 Elizabeth Josland CNC Outline Background of Renal Supportive Care Conservative Management Symptom overview Reading What does conservative management
More informationSYMPTOM CONTROL IN THE LAST DAYS OF LIFE. Bradford, Airedale, Wharfedale & Craven
Bradford, Airedale, Wharfedale & Craven Managed Clinical Network SYMPTOM CONTROL IN THE LAST DAYS OF LIFE Guidelines for Healthcare Professionals Bradford, Airedale, Wharfedale & Craven Signs and symptoms
More informationAgitation. Susan Emmens Palliative Care Clinical Nurse Specialist
Agitation Susan Emmens Palliative Care Clinical Nurse Specialist Definitions Restlessness finding or affording no rest, uneasy, agitated. Constantly in motion fidgeting Agitation shaking, moving, mental
More informationAnticipatory prescribing and end of life considerations. Dr Stephanie Lippett
Anticipatory prescribing and end of life considerations Dr Stephanie Lippett contents Pain Restlessness/agitation Nausea/vomiting Secretions Syringe driver Anticipatory prescribing Important things to
More informationAmy Voris DNP, AOCN, CNS
Amy Voris DNP, AOCN, CNS Objectives Define the difference between DNR-CC and DNR-CCA. Identify two comfort measures for the respiratory and gastrointestinal systems. Discuss the principles of hydration/enteral
More informationThe pain of it all. Rod MacLeod MNZM. Hibiscus Hospice, Auckland and University of Auckland
The pain of it all Rod MacLeod MNZM Hibiscus Hospice, Auckland and University of Auckland Definition of PAIN An unpleasant sensory and emotional experience which we primarily associate with tissue damage
More informationPalliative Care Impact Survey
September 2018 Contents Introduction...3 Headlines...3 Approach...4 Findings...4 Which guideline are used...4 How and where the guidelines are used...6 Alternative sources of information...7 Use of the
More informationGUIDELINES: Referral Guidelines to Nelson Tasman Hospice Service including Clinical Criteria for Patients
GUIDELINES: Referral Guidelines to Nelson Tasman Hospice Service including Clinical Criteria for Patients Overview Admission to the hospice service is NOT diagnosis specific and includes all patients with
More informationAnticipatory Medications for End of Life Patients. Doses must be proportional to the current analgesic medication YES NO YES NO
Anticipatory Medications for End of Life Patients oses must be proportional to the current analgesic medication Please refer ALL patients on Methadone or Ketamine to palliative care team for advice. Patients
More information20th June Integrated Care in Sunderland: Guide to Risk Stratification
20th June 2017 Integrated Care in Sunderland: Guide to Risk Stratification Table of Contents Integrated Care in Sunderland:... 1 Guide to Risk Stratification... 1 Table of Contents... 2 Background... 3
More informationNEUROPATHIC CANCER PAIN STANDARDS AND GUIDELINES
NEUROPATHIC CANCER PAIN STANDARDS AND GUIDELINES GENERAL PRINCIPLES Neuropathic pain may be relieved in the majority of patients by multimodal management A careful history and examination are essential.
More informationPalliative Emergencies. Ken Stakiw
Palliative Emergencies Ken Stakiw Disclosure None to disclose for this lecture Have received honoraria from a number of agencies and companies previously Intend to discuss some off label use of medications
More informationPalliative care in long-term conditions Scottish Palliative Care Pharmacists Association
Palliative care in long-term conditions 2011 2012 Scottish Palliative Care Pharmacists Association Aims & Objectives To explore symptoms, general management principles and appropriate palliative treatment
More informationAbby Woods, DNP, FNP Southern Illinois Healthcare Supportive Care Program END OF LIFE ISSUES IN THE CARE OF CARDIAC PATIENTS
Abby Woods, DNP, FNP Southern Illinois Healthcare Supportive Care Program END OF LIFE ISSUES IN THE CARE OF CARDIAC PATIENTS Objectives Describe a team approach in the setting of critical illness Differentiate
More informationBACKGROUND Measuring renal function :
A GUIDE TO USE OF COMMON PALLIATIVE CARE DRUGS IN RENAL IMPAIRMENT These guidelines bring together information and recommendations from the Palliative Care formulary (PCF5 ) BACKGROUND Measuring renal
More informationRoad Blocks in Non-Cancer Palliative Care Obstacles observed from outpatient non-cancer palliative practice.
Road Blocks in Non-Cancer Palliative Care Obstacles observed from outpatient non-cancer palliative practice. 25th Annual Palliative Education and Research Days, West Edmonton Mall. Edmonton. 2014 Amanda
More informationTRAJECTORY OF ILLNESS IN END OF LIFE CARE
TRAJECTORY OF ILLNESS IN END OF LIFE CARE By Dr Helen Fryer OBJECTIVES To be aware of the three commonest trajectories of decline in the UK To understand the challenges faced in delivering effective Palliative
More informationCare of dying adults in the last days of life. Improving care at the very end of life.
Care of dying adults in the last days of life Improving care at the very end of life. Foreword We will all experience death, whether it is our own or that of a loved one. The bereaved person s perception
More informationPalliative Care Asking the questions that matter to me
Palliative Care Asking the questions that matter to me THE PALLIATIVE HUB Adult This booklet has been developed by the Palliative Care Senior Nurses Network and adapted with permission from Palliative
More informationPalliative Care in a Dementia Unit: The Presbyterian Support Southland experience. Carla Arkless NP
Palliative Care in a Dementia Unit: The Presbyterian Support Southland experience Carla Arkless NP Overview What the literature is saying Palliative Care challenges Our experiences Case example What is
More informationCOPD AND PALLIATIVE CARE JEAN WATERS FNP-BC SENTARA RMH PALLIATIVE CARE JANUARY 13, 2018
COPD AND PALLIATIVE CARE JEAN WATERS FNP-BC SENTARA RMH PALLIATIVE CARE JANUARY 13, 2018 THOUGHTS TO CONSIDER What is Palliative Care? COPD and impact on Quality of Life. Prognosis and impact of co-morbidities
More informationWhat s New 2003? What new treatments? What have you discontinued? More information please!
What s New 2003? What new treatments? What have you discontinued? More information please! 1 What s New 2003? Submissions = 137 UK = 52 (38%) Doctors = 60% Nurses = 25% Pharmacists = 15% 2 What s New?
More informationHeart Failure Vital steps for palliative care. Dr Karen J Hogg Glasgow Royal Infirmary
Heart Failure Vital steps for palliative care Dr Karen J Hogg Glasgow Royal Infirmary Overview Why is heart failure a problem? Why do we need integrated cardiology and palliative care services? Cardiology
More informationManaging Care at End of Life:
Managing Care at End of Life: Physical Suffering Pain & Dyspnea Verna Sellers, MD, MPH, AGSF Medical Director Centra PACE Lynchburg, Virginia 1 Speaker Disclosures: Dr. Sellers has disclosed that she has
More information[Type text] Anticipatory Medication STAT dose and Syringe Driver Guidance [Type text]
[Type text] Anticipatory Medication STAT dose and Syringe Driver Guidance [Type text] Patients with egfr greater than 30mL/min Patients with egfr less than 30mL/min Symptom Drug Dose Symptom Drug Dose
More informationEnd of Life Care. Dr Anne Garry Consultant in Palliative Medicine
End of Life Care Dr Anne Garry Consultant in Palliative Medicine Concerns voiced both by public and professionals.. Implementation and on-going training highly variable across country Decisions made by
More informationTraining in palliative and end-of-life care: Guidance for trainees (and their trainers) in non-palliative medicine training posts
Training in palliative and end-of-life care: Guidance for trainees (and their trainers) in non-palliative medicine training posts August 204 Produced by Dr Fiona Hicks onsultant in Palliative Medicine
More informationAgeing & Palliation. Dr. Thiru Thirukkumaran Palliative Care Services Northwest Tasmania
Ageing & Palliation Dr. Thiru Thirukkumaran Palliative Care Services Northwest Tasmania How this Session is planned? What is palliative Care? What changes take place when a young adult becomes elderly?
More informationThe Palliative Care Journey. By Sandra O Sullivan Clinical Nurse Manager 1 St Luke's home
The Palliative Care Journey By Sandra O Sullivan Clinical Nurse Manager 1 St Luke's home Aims 1. To provide an overview of what palliative care involves. 2. Identify, at what stage should Dementia be acknowledged
More informationDelivering personalised care to end of life patients. Jane Naismith Nurse Consultant in Palliative care St Joseph s Hospice London
Delivering personalised care to end of life patients Jane Naismith Nurse Consultant in Palliative care St Joseph s Hospice London Over View This session will cover Supporting patients with long term conditions
More informationSupportive and Palliative care for patients with Pancreatic Cancer. Dr Holly Taylor September 2018
Supportive and Palliative care for patients with Pancreatic Cancer Dr Holly Taylor September 2018 Aims of this session To discuss the principles of supportive and palliative care Identification of patients
More informationEmergency Control of the Acutely Disturbed Adult Patient GUIDELINES ON EMERGENCY CONTROL OF THE ACUTELY DISTURBED ADULT PATIENT... 2 ACTION...
Delirium Toolkit Emergency Control of the Acutely Disturbed Adult Patient Table of Contents GUIDELINES ON EMERGENCY CONTROL OF THE ACUTELY DISTURBED ADULT PATIENT... 2 ACTION... 2 AFTERCARE... 3 NOTES...
More information